These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9002382)

  • 1. Hypercholesterolemia and the progression of the renal dysfunction in chronic renal failure patients.
    Washio M; Okuda S; Ikeda M; Hirakata H; Nanishi F; Onoyama K; Yoshimura T; Fujishima M
    J Epidemiol; 1996 Dec; 6(4):172-7. PubMed ID: 9002382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of progression of chronic renal failure--using reciprocal of serum creatinine.
    Muthusethupathi MA; Kumar SS; Sekaran L
    J Assoc Physicians India; 1989 Mar; 37(3):213-6. PubMed ID: 2768164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol falls spontaneously in nephrotic patients with progressive renal disease.
    Moorhead JF; Persaud W; Varghese Z; Sweny P
    Ren Fail; 1993; 15(3):389-93. PubMed ID: 8516496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
    Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
    Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis].
    Kacso I; Gherman M; Mazouz H; Ghazali A; el Esper N; Morinière P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):19-28. PubMed ID: 10081033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of dietary intake and serum lipids interact with proteinuria as risk factors for progression of chronic renal failure.
    Boaz M; Biro A; Katzir Z; Smetana S
    Ren Fail; 1998 Mar; 20(2):383-90. PubMed ID: 9574466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of heart rate as a risk factor associated with the progression of chronic renal failure].
    Mora-Maciá J; Cases A; Alami M; Agraz I; Barceló P; Esqué J
    Med Clin (Barc); 2002 Sep; 119(7):245-8. PubMed ID: 12236983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
    Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
    Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting progression of renal failure in patients with type 2 diabetes.
    Ueda H; Ishimura E; Shoji T; Emoto M; Morioka T; Matsumoto N; Fukumoto S; Miki T; Inaba M; Nishizawa Y
    Diabetes Care; 2003 May; 26(5):1530-4. PubMed ID: 12716817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure.
    Niwa T; Aoyama I; Takayama F; Tsukushi S; Miyazaki T; Owada A; Shiigai T
    Miner Electrolyte Metab; 1999; 25(1-2):118-22. PubMed ID: 10207273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of urinary methylguanidine in non-dialyzed patients with chronic renal failure--prediction of progression rate of renal dysfunction].
    Koda Y; Saito A; Shinohara K; Ei R; Miyazaki S; Yuasa Y; Sakai S; Suzuki M; Takahashi S; Hirasawa Y
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):203-8. PubMed ID: 8501848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of atherosclerotic coronary artery disease and pulse pressure with renal disease progression.
    Kim SB; Kwon S; Lee SK; Park JS
    Ren Fail; 2003 Nov; 25(6):1019-27. PubMed ID: 14669861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenting of renal artery stenosis: is it beneficial in chronic renal failure?
    Rivolta R; Bazzi C; Stradiotti P; Paparella M
    J Nephrol; 2005; 18(6):749-54. PubMed ID: 16358234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous changes in the rate of decline in reciprocal serum creatinine: errors in predicting the progression of renal disease from extrapolation of the slope.
    Shah BV; Levey AS
    J Am Soc Nephrol; 1992 Jan; 2(7):1186-91. PubMed ID: 1591359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.
    Mora-Macía J; Cases A; Calero F; Barceló P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():82-4. PubMed ID: 11369829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
    Samuelsson O; Lee DM; Attman PO; Knight-Gibson C; Mullen JK; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1999; 82(4):306-11. PubMed ID: 10450032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
    Baigent C; Landray M; Leaper C; Altmann P; Armitage J; Baxter A; Cairns HS; Collins R; Foley RN; Frighi V; Kourellias K; Ratcliffe PJ; Rogerson M; Scoble JE; Tomson CR; Warwick G; Wheeler DC
    Am J Kidney Dis; 2005 Mar; 45(3):473-84. PubMed ID: 15754269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy.
    Syrjänen J; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 2000 Jan; 15(1):34-42. PubMed ID: 10607765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for progression of diabetic nephropathy.
    Yokota C; Kimura G; Inenaga T; Kawano Y; Matsuoka H; Omae T
    Am J Nephrol; 1995; 15(6):488-92. PubMed ID: 8546170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.